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Abstract Non-homologous end-joining is an important path-
way for the repair of DNA double-strand breaks. This type of
DNA break is followed by the rapid phosphorylation of Ser-139
in the histone variant H2AX to form Q-H2AX. Here we report
e⁄cient in vitro end-joining of reconstituted chromatin contain-
ing nucleosomes made with either H2A or H2AX. This reaction
is catalyzed by nuclear extracts from human cells and this end-
joining is not suppressed by the PI-3 kinase inhibitor wortman-
nin. During the end-joining reaction H2AX is phosphorylated at
Ser-139 as detected by immunoblot with speci¢c antibodies and
this phosphorylation is inhibited by wortmannin. Therefore, in
vitro the DNA end-joining reaction appears to be independent of
H2AX phosphorylation. , 2002 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The correct repair of DNA double-strand breaks (DSBs) is
an important mechanism for maintaining the stability of
mammalian genomes. Two major pathways of DSB repair
are known: non-homologous end-joining (NHEJ) which is
controlled by a DNA-dependent protein kinase, the protein
XRCC4 and DNA ligase IV [1^3], and homologous recombi-
nation (HR) which is controlled by the mammalian homologs
and paralogs of the yeast RAD50 and RAD51 proteins [4,5].
It was shown that the formation of DSBs in mammalian cells
induces the rapid phosphorylation of Ser-139 in the histone
H2AX [6,7]. This histone modi¢cation is important for DSB
repair in vivo, since inactivation of the H2AX gene in mice
results in radiosensitivity and chromosome instability [8]. It
has been suggested that chromatin containing Q-H2AX pro-
motes assembly of DSB repair complexes [8,9] but the molec-
ular basis of this process remains to be established.
Here we describe an in vitro end-joining assay to analyze
the interactions of chromatin with DSB repair proteins. Hu-
man histones H2A, H2AX, H2B, H3 and H4 were used to
reconstitute chromatin of de¢ned content on a 3.8 kb DNA
substrate. Incubation of chromatin with nuclear extract led to
end-joining with a much higher e⁄ciency than that of naked
DNA. This nuclear extract was found to catalyze the forma-
tion of Q-H2AX, however, the end-joining reaction was inde-
pendent of the presence of H2AX in the chromatin.
2. Materials and methods
2.1. Human cell lines and isolation of nuclear extracts
Cell lines A549 and IMR-90 were obtained from the ATCC, cell
line CRL-7201 from Coriell Cell Repositories. A549 cells were culti-
vated in RPMI 1640 medium supplemented with 10% fetal calf serum
(FCS). Primary ¢broblasts of the cell lines CRL-7201 and IMR-90
were maintained in DMEM with 10% FCS. Cells were washed in PBS
and then incubated in two volumes (packed cells) of hypotonic bu¡er
(20 mM Tris^HCl pH 8, 1 mM dithiothreitol (DTT)) for 30 min on
ice. The cells were then disrupted by passing ¢ve times through a 24-
gauge needle. Protease inhibitor mix (Roche) was added and the nu-
clei pelleted by centrifugation. Nuclei were extracted by incubation for
30 min on ice in 0.5 M KCl, 20 mM Tris^HCl pH 7.5, 1 mM EDTA,
1 mM DTT and the soluble nuclear extract was separated from cell
debris by centrifugation for 1 min in an Eppendorf centrifuge.
2.2. Expression and puri¢cation of recombinant human histone H2AX
(rhH2AX)
A rhH2AX gene was constructed from a Xenopus histone H2A
pET3a kindly provided by K. Luger [10]. First, part of the Xenopus
H2A gene was replaced with bacterially optimized codons for the
carboxy-terminal 13 amino acids of human H2AX using a ‘touch-
down’ PCR method [11] along with Thermozyme1 DNA Polymerase
(Invitrogen), and a combination of the following overlapping primers
(Gibco-BRL): T7 promoter CCCGCGAAATTAATACGACTCA;
H2AXC1 TTCGGACCAACGGTAGCGGAGGTTTTCTTGGGC-
AGCAGCACGGA; H2AXC2 GGGTAGCTTTTTTACCACCGGA-
CGGAGCTTTCGGACCAACGGTAGCGGAGGTT; H2AXC3 G-
GATCCTTAGTATTCCTGGGAAGCCTGGGTAGCTTTTTTACC-
ACCGGACGGAG.
Next, 14 codon changes were made to produce a bacterially opti-
mized rhH2AX gene using the following primers (Gibco-BRL): X1A
ATGTCTGGACGTGGCAAAACCGGCGGTAAAGCTCGCGCT-
AAGGCCAAGTCTCGCTC; X1B GAAGGAGATATACATAT-
GTCTGGACGTGGCAAAACCG; X2 TCTGCATAATGGCCT-
TTCCGTAACAGCCG; X3 GGCTGTTACGGAAAGGCCATTA-
TGCAGAGCG; X4 ACCTCCGAGCAGTTTGTTCAGTTCCT-
CATCGTTGCGGATAGCGAGCTGC; X5A CAGGGCGGTGT-
CCTGCCGAACATCCAGGCCGTGCTGCTGCCGAAGAAAAC;
X5B GAACAAACTGCTCGGAGGTGTCACTATCGCTCAGGG-
CGGTGTCCTGCCGAAC; X5C ATCCGCAACGATGAGGAA-
CTGAACAAACTGCTCGGAGGTGTC; X6 CCAACTCAGCTT-
CCTTTCGGGCTTTG.
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Primer sets X1A/X1B with X2, X3 with X4, and X5A/X5B/X5C
with X6 were used for PCR and then 0.25 Wl from each reaction was
combined in a fourth reaction containing the primer pair X1B and X6
to PCR ligate the overlapping gene fragments into a 488 bp rhH2AX
gene cassette. This gene construct was subcloned into pCR2.1
(Topo1TA Cloning0, Invitrogen) and grown in Top10 Escherichia
coli. Standard methods [12] were used to subclone the NdeI/BamHI
(New England Biolabs) rhH2AX coding cassette into pET3a. H2AX-
pET3a was sequenced and then transformed into BL21(DE3) pLysS
for IPTG-inducible protein expression (Novagen).
Inclusion bodies were isolated from the bacterial lysate and dis-
solved into 7 ml of 7 M guanidinium hydrochloride, 20 mM Tris^
HCl pH 7.5, 10 mM L-mercaptoethanol per liter of cell culture [10].
The dissolved protein was ¢ltered (0.45 micron) and loaded onto a
Superose 12 column (2.5U100 cm). FPLC was conducted at a £ow
rate of 1 ml/min and the entire run was complete after 500 ml of
bu¡er (7 M urea, 1.2 M NaCl, 20 mM sodium acetate pH 5.2,
5 mM L-mercaptoethanol, 1 mM EDTA). The major H2AX fractions
were combined and dialyzed in 8 kDa molecular weight cut o¡
(MWCO) dialysis tubing (BioDesign Inc.) against three changes of
4 l distilled water at 4‡C. Lyophilized protein was then dissolved in
1 ml of Inclusion Body Solubilization1 bu¡er (Genotech) and 4 ml of
7 M urea, ¢ltered (0.45 micron), and puri¢ed to homogeneity by
reverse phase high-performance liquid chromatography (HPLC) on
a prep-scale Vydac C4 column (2.2U25 cm). A gradient of 30^60%
acetonitrile (0.1% tri£uoroacetic acid) in 60 min was used at a £ow
rate of 9.9 ml/min. The peak H2AX fractions were combined and
lyophilized. The H2AX was checked by matrix-assisted laser desorp-
tion/ionization-time of £ight mass spectrometry (Protein Resource
Center, The Rockefeller University) and the protein concentration
determined by amino acid analysis (Biomolecular Structure Lab,
UC Davis).
2.3. DNA and histone puri¢cation
A plasmid (pUC208-18) containing substrate DNA was ampli¢ed in
bacteria, isolated, and restriction-digested with CfoI. The 3.8 kb frag-
ment containing 18 repeats of a nucleosome positioning sequence was
puri¢ed by MonoQ (Pharmacia) FPLC [13]. Puri¢cation of the indi-
vidual HeLa cell core histones by acid extraction, ion exchange chro-
matography and C4 reverse phase HPLC was conducted as described
previously [14]. Native chicken erythrocyte (C.E.) histone octamers
were isolated from nuclei as described earlier [15].
2.4. Chromatin reconstitution and characterization
Stoichiometric amounts of the four core histones (either HeLa
H2A, H2B, H3, and H4 or rhH2AX and HeLa H2B, H3, and H4)
were combined with 25 Wg of substrate DNA in a starting bu¡er
containing 4 M urea and 1.8 M NaCl in a microdialyzer using
8 kDa MWCO membrane (BioDesign Inc.). This mixture was equil-
ibrated with bu¡er A (7.4 M urea, 2 M NaCl, 20 mM Tris^HCl pH
7.5, 0.1 mM EDTA, 10 mM L-mercaptoethanol). A linear gradient of
bu¡er A and bu¡er B (2 M NaCl, 20 mM Tris^HCl pH 7.5, 0.2 mM
EDTA, 10 mM L-mercaptoethanol, 0.1 mM PMSF) followed by a
gradient of bu¡er B and bu¡er C (10 mM NaCl, 10 mM triethanol-
amine pH 8.0, 0.2 mM EDTA, 5 mM L-mercaptoethanol) was used
for chromatin reconstitution [16]. An aliquot of each sample for use in
microscopy was crosslinked in bu¡er C containing 0.15% glutaralde-
hyde for 15 h and then equilibrated with bu¡er C. All dialysis was
conducted at 4‡C and each gradient was pumped over 7 h. Samples of
the reconstituted chromatin (1.5 Wg) were digested with 0.1 unit of
micrococcal nuclease in bu¡er supplemented with 1 mM calcium at
37‡C for 10 min. The reaction was stopped by addition of EDTA. The
digested chromatin core particles were then examined on a native
polyacrylamide gel (5% acrylamide, 0.5UTBE bu¡er pH 8.0) con¢rm-
ing proper nucleosome core reconstitution.
2.5. Atomic force microscopy (AFM)
Crosslinked chromatin was diluted to approximately 3 ng/Wl in
0.2 mM MgCl2 and immediately deposited (12 Wl) onto freshly cleaved
mica. After 5 min the mica was rinsed with 2 ml of Nanopure water
(Millipore), dried with nitrogen gas and imaged at ambient temper-
ature and humidity using a Nanoscope 3a AFM (Digital Instru-
ments). Three micron images were scanned at a rate of 1.3 Hz with
an FESP tip (Digital Instruments) using Tapping mode. Images were
processed, rendered, and analyzed using Digital Instruments Nano-
scope software and Scion Image (Scion Corp.).
2.6. End-joining reactions and immunoblot analysis of Q-H2AX
Reaction mixes (50 Wl each) contained 20 mM Tris^HCl pH 7.5,
1 mM ATP, 10 mM DTT, 10 mM MgCl2 (if not otherwise indicated),
2 Wl of nuclear extract (2^3 Wg of total protein) and 200 ng of the 208-
18 DNA substrate or the equivalent amount of 208-18 reconstituted
chromatin. After incubation for 90 min at room temperature 2 Wl of
solution containing 20 Wg of proteinase K was added and incubation
continued for 60 min at 37‡C. The reaction products were separated
in a 0.5UTBE 0.6% agarose gel. The gel was stained with ethidium
bromide and images captured using a CCD camera (Alpha Inotech)
with a UV transluminator (UVP). Western blot analysis of Q-H2AX
was conducted as previously described [17].
3. Results
The 3.8 kb DNA substrate (208-18 DNA), HeLa cell core
histones, and bacterially expressed rhH2AX used in this study
were all puri¢ed individually to homogeneity using gel ¢ltra-
tion, ion exchange, and reverse phase chromatography. This
allowed the reconstitution of chromatin with exactly de¢ned
content. Micrococcal nuclease digestion of the H2AX chro-
matin (Fig. 1A, lane 4) produced nucleosome core particles
(NCPs) indistinguishable from control erythrocyte (Fig. 1A,
lane 1) and reconstituted HeLa NCPs (lane 3). Fig. 1B shows
a typical image of the reconstituted H2AX-containing 208-18
chromatin visualized using AFM. This chromatin appears
normal and was determined to contain an average of 10 nu-
cleosomes per ¢ber (n=64) with a standard deviation of 1.5
and a range of 6^14 nucleosomes. Naked DNA was not found
in these samples. Similar results were obtained with chromatin
containing normal histone H2A. Fig. 1C shows an AFM im-
Fig. 1. Characterization of reconstituted chromatin. A: Micrococcal
nuclease digestion of lane 1 ^ C.E. chromatin, lane 3 ^ HeLa chro-
matin, lane 4 ^ H2AX chromatin. Lane 2 shows a 100 bp DNA
ladder. B, C: Images of reconstituted H2AX chromatin (B) and re-
constituted HeLa (H2A) chromatin (C) obtained by AFM. The
maximum vertical scale on AFM images is 12 nm (white). D: DNA
packaging in reconstituted chromatinWone standard deviation (bp
per nucleosome) calculated from chromatin contour plots containing
the given number of chromatin ¢bers (Count).
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age of reconstituted HeLa control chromatin (containing nor-
mal histone H2A) also used in our experiments. Analysis of
many AFM images of the chromatin allowed chromatin con-
tour plots to be made comparing nucleosome loading to ¢ber
length [23]. From these plots the DNA packaging values of
the various chromatin were calculated and found to be 146 bp
per nucleosome as expected for normal nucleosome cores (see
the table in Fig. 1D).
After incubation of the reconstituted H2A- or H2AX-con-
taining chromatin with nuclear extract from human A549 cells
followed by digestion of proteins with proteinase K, the DNA
end-joining products were separated and analyzed in a 0.6%
agarose gel (Fig. 2A, lanes 4 and 6). A control reaction per-
formed with the 208-18 substrate DNA showed much less
e⁄cient ligation (Fig. 2A, lane 2) as compared to chromatin
containing either H2A (lane 4) or H2AX (lane 6). This indi-
cates that chromatin is a preferred substrate for the in vitro
end-joining.
Sedimentation studies have shown that subsaturated nucle-
osome arrays do not condense e⁄ciently even in 10 mM
Mg2þ, however oligomerization does occur [24^26] which
could promote end-joining. As shown in Fig. 2B (lanes 2^5),
decreasing the MgCl2 concentration in the reaction mix with
H2AX chromatin from 10 to 1.25 mM strongly decreases end-
joining e⁄ciency but only slightly decreases end-joining of the
208-18 DNA substrate (Fig. 2B, lanes 8 and 9). It is obvious,
however, that the naked DNA substrate end-joins poorly in
these reactions regardless of the Mg2þ concentration. At 1.25
mM MgCl2 the 1 mM ATP in the reaction should chelate
most of the Mg2þ, leaving only about 0.25 mM free which
is too low to promote chromatin oligomerization [24] and
possibly low enough to beginning a¡ecting the rate of the
ligation reaction. These results are consistent with the view
that Mg2þ-mediated chromatin association facilitates in vitro
end-joining possibly by juxtaposing the DNA ends for liga-
tion.
To determine whether H2AX is phosphorylated at Ser-139
during the in vitro chromatin ligation we immunoblotted the
reaction mixes with antibodies against a Ser-139 phosphory-
lated H2AX peptide. In vivo DSB-induced phosphorylation of
H2AX in chromatin is known to be inhibited by pre-treatment
of cells with wortmannin, an inhibitor of PI-3 kinases [9,18].
We pre-incubated the nuclear extracts from three human cell
lines with di¡erent concentrations of wortmannin. Fig. 3A
shows that Q-H2AX is formed during the in vitro end-joining
and that this phosphorylation is inhibited by wortmannin.
However, in these reactions chromatin end-joining is not in-
hibited (Table 1) by the same concentrations of wortmannin
(20 and 200 WM) which inhibited Q-H2AX formation. This
indicates that in vitro H2AX phosphorylation is decoupled
from DNA end-joining. This conclusion is supported by the
observation of e⁄cient end-joining of the control chromatin
(Fig. 2A, lane 3), containing histone H2A which lacks a
C-terminal SQEY recognition sequence for PI-3 kinase phos-
phorylation.
Fig. 2. Reconstituted chromatin and DNA end-joining by A549 hu-
man cell nuclear extract. All images show ethidium bromide-stained
0.6% agarose gels. A: Products of end-joining in 10 mM MgCl2 of
naked 208-18 DNA (lane 2), H2A chromatin (lane 4) and H2AX
chromatin (lane 6); lanes 1, 3 and 5 show corresponding controls
without nuclear extract. In (B), lanes 2^6 reactions with H2AX
chromatin were performed at 10, 5, 2.5, 1.25 and 0 mM MgCl2, re-
spectively. Lanes 8 and 9 show products of reactions with naked
208-18 DNA incubated at 10 and 1.25 mM MgCl2. Lanes 1 and 7
show controls with H2AX chromatin and DNA without nuclear ex-
tract.
Fig. 3. Phosphorylation of histone H2AX during end-joining of
H2AX chromatin by human nuclear extracts prepared from di¡erent
cell lines. A 10 Wl aliquot of the standard end-joining reactions (see
Table 1 for results) was separated by SDS^PAGE and blotted using
antibodies against Q-H2AX. Nuclear extracts were pre-treated at the
indicated concentrations of wortmannin for 30 min on ice.
Table 1
Wortmannin does not inhibit in vitro end-joining of chromatin
Cell line [Wortmannin] (WM)
0 20 200
A549 44.3a 42.9 44.3
CRL-7201 41.0 39.6 40.6
IMR-90 41.5 39.8 41.1
aPercent end-joining products produced by extracts pre-treated for
30 min on ice with the indicated concentration of wortmannin
(WM).
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4. Discussion
We demonstrated here a nuclear extract-mediated end-join-
ing reaction that preferentially and e⁄ciently utilizes chroma-
tin as a substrate instead of DNA. The reaction shows MgCl2
dependence. A decrease of MgCl2 concentration below levels
known to promote chromatin self-association resulted in the
same low e⁄ciency of end-joining of both naked DNA and
chromatin. This may indicate that chromatin oligomerization
(or higher order organization) mediated by magnesium (and
possibly other nuclear proteins) helps to promote the end-
joining reaction and may be important for DSB repair in
vivo. Surprisingly, chromatin composed of H2A-containing
nucleosomes was end-joined just as e⁄ciently as chromatin
composed with H2AX. When H2AX was present, the reaction
resulted in the phosphorylation of Ser-139 in histone H2AX
and Q-H2AX formation was wortmannin-sensitive. However,
the end-joining of chromatin was not inhibited by pre-incu-
bation of nuclear extracts with wortmannin. This indicates
that the in vitro phosphorylation of H2AX and chromatin
end-joining may be uncoupled. Wortmannin-insensitive
DNA end-joining reactions by mammalian cell extracts were
described in many other studies, reviewed in [27]. Some work-
ers have isolated extracts that catalyze wortmannin-sensitive
DNA end-joining reactions [28], but it remains to be estab-
lished whether these extracts are able to perform wortmannin-
sensitive end-joining of chromatin.
Free histone H2AX in known to be phosphorylated in vitro
at Ser-139 by a kinase present in mammalian nuclear extract
[6]. In our experiments some free histones were present in the
reconstituted chromatin preparations, so it remains unclear
whether the observed H2AX phosphorylation occurs at chro-
matin bound H2AX (within nucleosomes) or only upon free
histone. Although this question is of interest for future experi-
ments it has no bearing on the present study since the in vitro
end-joining of chromatin observed was not dependent on the
presence of H2AX.
A strong correlation between DSBs and Q-H2AX formation
was observed in vivo [6,7,9] suggesting the existence of mech-
anisms coupling H2AX phosphorylation and its elimination
to DSB repair. It was shown that at least two wortmannin-
sensitive protein kinases are involved in H2AX phosphoryla-
tion: ATM kinase [18] and ATR kinase [19], but the mecha-
nism of Q-H2AX elimination from chromatin after DSB repair
is unknown. This elimination should be linked to chromatin
re-assembly after DSB repair [20]. ATM kinase is defective in
the chromosome instability syndrome ataxia teleangiectasia
(AT) and both AT cells and cells from ATM-de¢cient mice
show strongly decreased H2AX phosphorylation after treat-
ment with ionizing radiation [18]. However, human AT and
mouse ATM (3/3) cells have no major defect in NHEJ repair
of radiation-induced DSBs [21] indicating that the catalytic
steps of end-joining in vivo may also be uncoupled from
H2AX phosphorylation. Alternatively, other protein kinases
may be involved in the formation of Q-H2AX.
DSB repair in vivo includes not simply DNA end-joining
but also the prevention of rejoining incorrect DNA ends (mis-
joining) and the control of unequal HR between repeats (mis-
recombination). The frequency of DNA misjoining is in-
creased in human AT cells [22] and the cells from H2AX
knockout mice show remarkable chromosome instability [8].
These observations suggest that while H2AX is not necessary
for chromatin end-joining, the formation and removal of
Q-H2AX may be critical in the control of misjoining.
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